Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain, AccA2 | 0.1462 | 0.3345 | 1 |
Echinococcus multilocularis | propionyl coenzyme A carboxylase alpha chain | 0.1462 | 0.3345 | 0.3345 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.1462 | 0.3345 | 0.5531 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.1462 | 0.3345 | 0.3226 |
Schistosoma mansoni | P2X receptor subunit | 0.1604 | 0.3741 | 0.3629 |
Chlamydia trachomatis | biotin carboxylase | 0.1328 | 0.2969 | 1 |
Mycobacterium ulcerans | propionyl-CoA carboxylase beta chain 4 AccD4_2 | 0.052 | 0.0708 | 0.1676 |
Mycobacterium ulcerans | bifunctional protein acetyl-/propionyl-coenzyme a carboxylase (alpha chain) AccA3 | 0.1462 | 0.3345 | 1 |
Leishmania major | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.052 | 0.0708 | 0.0708 |
Mycobacterium ulcerans | propionyl-CoA carboxylase beta chain 4 AccD4 | 0.052 | 0.0708 | 0.1676 |
Leishmania major | carbamoyl-phosphate synthase, putative | 0.033 | 0.0177 | 0.0177 |
Leishmania major | methylcrotonoyl-coa carboxylase biotinylated subunitprotein-like protein | 0.1462 | 0.3345 | 0.3345 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.1604 | 0.3741 | 0.3741 |
Mycobacterium tuberculosis | Probable pyruvate carboxylase Pca (pyruvic carboxylase) | 0.1462 | 0.3345 | 1 |
Trypanosoma cruzi | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.052 | 0.0708 | 0.0927 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.1462 | 0.3345 | 0.5531 |
Echinococcus multilocularis | propionyl coenzyme A carboxylase beta chain | 0.052 | 0.0708 | 0.0708 |
Schistosoma mansoni | propionyl-CoA carboxylase beta chain mitochondrial precursor | 0.052 | 0.0708 | 0.0541 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.1604 | 0.3741 | 0.3741 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.1604 | 0.3741 | 0.3741 |
Mycobacterium leprae | Probable bifunctional protein acetyl-/propionyl-coenzyme A carboxylase, alpha chain AccA3 (BccP) | 0.1462 | 0.3345 | 1 |
Mycobacterium tuberculosis | Probable acetyl-/propionyl-coenzyme A carboxylase alpha chain (alpha subunit) AccA2: biotin carboxylase + biotin carboxyl carrie | 0.1462 | 0.3345 | 1 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.1604 | 0.3741 | 0.3741 |
Mycobacterium ulcerans | propionyl-CoA carboxylase beta chain 5 AccD5 | 0.052 | 0.0708 | 0.1676 |
Leishmania major | carboxylase, putative | 0.1462 | 0.3345 | 0.3345 |
Toxoplasma gondii | pyruvate carboxylase | 0.1462 | 0.3345 | 0.3226 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.1462 | 0.3345 | 0.3226 |
Leishmania major | propionyl-coa carboxylase beta chain, putative | 0.052 | 0.0708 | 0.0708 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.1604 | 0.3741 | 0.3741 |
Leishmania major | acetyl-CoA carboxylase, putative | 0.3839 | 1 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.1604 | 0.3741 | 0.3629 |
Schistosoma mansoni | P2X receptor subunit | 0.1604 | 0.3741 | 0.3629 |
Echinococcus granulosus | propionyl coenzyme A carboxylase alpha chain | 0.1462 | 0.3345 | 0.3345 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.1462 | 0.3345 | 0.3226 |
Schistosoma mansoni | P2X receptor subunit | 0.1604 | 0.3741 | 0.3629 |
Trypanosoma cruzi | acetyl-CoA carboxylase | 0.2376 | 0.5906 | 1 |
Trypanosoma brucei | unspecified product | 0.0961 | 0.1943 | 0.1798 |
Mycobacterium ulcerans | acetyl-coenzyme a carboxylase carboxyl transferase (subunit beta) AccD3 | 0.052 | 0.0708 | 0.1676 |
Wolbachia endosymbiont of Brugia malayi | Acetyl-CoA carboxylase, carboxyltransferase component | 0.052 | 0.0708 | 0.1676 |
Toxoplasma gondii | acyl-CoA carboxyltransferase beta chain, putative | 0.052 | 0.0708 | 0.0541 |
Mycobacterium ulcerans | pyruvate carboxylase | 0.1462 | 0.3345 | 1 |
Echinococcus granulosus | propionyl coenzyme A carboxylase beta chain | 0.052 | 0.0708 | 0.0708 |
Entamoeba histolytica | acetyl-coA carboxylase, putative | 0.0655 | 0.1084 | 0.5 |
Plasmodium vivax | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.2778 | 0.703 | 1 |
Schistosoma mansoni | acetyl-CoA carboxylase | 0.3839 | 1 | 1 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain AccA1 | 0.1462 | 0.3345 | 1 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.1462 | 0.3345 | 0.3226 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.1604 | 0.3741 | 0.3741 |
Trypanosoma brucei | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.052 | 0.0708 | 0.0541 |
Wolbachia endosymbiont of Brugia malayi | Acetyl/propionyl-CoA carboxylase, alpha subunit | 0.1462 | 0.3345 | 1 |
Echinococcus multilocularis | acetyl coenzyme A carboxylase 1 | 0.3839 | 1 | 1 |
Toxoplasma gondii | acetyl-coA carboxylase ACC2 | 0.3839 | 1 | 1 |
Giardia lamblia | Acetyl-CoA carboxylase/pyruvate carboxylase fusion protein, putative | 0.0655 | 0.1084 | 0.5 |
Trypanosoma cruzi | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.052 | 0.0708 | 0.0927 |
Mycobacterium ulcerans | acetyl/propionyl CoA carboxylase subunit beta | 0.052 | 0.0708 | 0.1676 |
Mycobacterium ulcerans | acetyl-/propionyl-CoA carboxylase subunit beta | 0.052 | 0.0708 | 0.1676 |
Toxoplasma gondii | acetyl-CoA carboxylase ACC1 | 0.3839 | 1 | 1 |
Schistosoma mansoni | pyruvate carboxylase | 0.1462 | 0.3345 | 0.3226 |
Loa Loa (eye worm) | carboxyl transferase domain-containing protein | 0.3704 | 0.9624 | 0.5 |
Brugia malayi | Carboxyl transferase domain containing protein | 0.3704 | 0.9624 | 0.5 |
Trypanosoma brucei | acetyl-CoA carboxylase | 0.3839 | 1 | 1 |
Plasmodium falciparum | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.2778 | 0.703 | 1 |
Trypanosoma cruzi | acetyl-CoA carboxylase, putative | 0.052 | 0.0708 | 0.0927 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.